New imaging tech listens to radiation to improve prostate cancer treatment
NCT ID NCT06465966
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests a new imaging method called iRAI that uses sound waves to monitor proton radiation delivery in real time for prostate cancer patients. Researchers will compare the actual radiation dose measured by iRAI with the planned dose from CT scans. The goal is to see if iRAI can accurately track where the radiation goes, which could help make treatments more precise. About 30 participants will be enrolled.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ionizing-radiation photo acoustic imaging (iRAI) device
What this could lead to
If successful, this could lead to more precise proton radiation delivery for prostate cancer, potentially reducing side effects.
What could go wrong
This is a small, early-stage feasibility study (30 people) focused on imaging accuracy, not treatment outcomes. The technology may not improve patient results or may have technical limitations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Univeristy of Florida Health Proton Therapy Institute
RECRUITINGJacksonville, Florida, 32206, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••